Skip to content
Search

Latest Stories

GPhC seeks views on draft standards for chief pharmacists

Patients, carers, and members of the public are encouraged to share what they think about the new draft standards

The General Pharmaceutical Council (GPhC) has developed new draft Standards for Chief Pharmacists to strengthen pharmacy governance.


It has set out the professional responsibilities as well as described the knowledge, conduct, and performance required by a chief pharmacist (or equivalent) to support their organisation and its staff to deliver "safe and effective" pharmacy services.

The pharmacy regulator has also launched a consultation to find out what patients, carers, and members of the public think about the new draft standards.

Participants can share their views “if there are any settings in which the standards could not be applied or met and any positive or negative impacts of the proposals," it said.

The survey will open for 12 weeks, from 23 January to 16 April 2024.

GPhC Chief Executive Duncan Rudkin commented: “Our draft Standards for chief pharmacists will complement our existing standards for all pharmacy professionals, strengthening assurance around these critical roles and empowering pharmacy professionals at a time of great challenge and opportunity for the professions.

“We are committed to listening carefully to all views expressed to make sure that the standards reflect the views and needs of patients and the public, health professionals, the NHS and the wider health sector.”

These draft standards were developed following new legislation which “removes the threat of criminal penalties for accidental or unintentional preparation and dispensing errors by pharmacy staff working in hospitals and similar settings,” the council clarified.

It emphasised that protection from prosecution helps to promote an "open and learning culture" which is vital for patient safety.

These rules already apply to pharmacy staff working in registered pharmacies (community pharmacies).

Further, it elaborated that to benefit from the new rules, a hospital (or relevant setting) must have a Chief Pharmacist (or equivalent) in post, who must be a registered pharmacist with the appropriate skills, training, and experience; and they must meet the Standards for Chief Pharmacists.

This is part of a wider programme, which aims to provide clarity around how pharmacies are organised and managed to ensure that patients and the public continue to receive safe and effective pharmacy care, the council added.

In the future, the regulator plans to develop and organise consultations on rules and professional standards for responsible pharmacists, and professional standards for superintendent pharmacists.

 

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less